Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aeovian Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aeovian Pharmaceuticals

Aeovian Pharmaceuticals

Series A

Aeovian Pharmaceuticals: Innovating treatments for rare and age-related diseases since 2012.

HQ
San Francisco, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in 2012, Aeovian Pharmaceuticals is a biopharmaceutical company based in the San Francisco Bay Area. The company's core mission is to discover, develop, and commercialize innovative therapeutics for treating rare and age-related diseases. Aeovian focuses on developing compounds that modulate molecular pathways to address the underlying causes of disease initiation and progression, such as oxidative, cellular, and environmental stress. Their lead development candidate, AV078, is currently in Phase clinical trials for treating seizures associated with Tuberous Sclerosis Complex (TSC).

Notable figures affiliated with Aeovian Pharmaceuticals include William Greene, MD, CIO at Hevolution, and Justin Gover, former CEO at GW Pharmaceuticals, both of whom have joined the board. The company has achieved significant milestones, including dosing the first cohort of participants in their Phase clinical trial and securing additional financing. Aeovian's innovative approach and strategic leadership have positioned it as a promising player in the biopharmaceutical industry, with a focus on impactful treatments for underserved patient populations.

Aeovian Pharmaceuticals - Similar Companies

Azevan Pharmaceuticals logo

Azevan Pharmaceuticals

azevan.com

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Abvc Biopharma logo

Abvc Biopharma

Aether Therapeutics logo

Aether Therapeutics

Apexian Pharmaceuticals logo

Apexian Pharmaceuticals

apexianpharma.com

Aquavit Pharmaceuticals logo

Aquavit Pharmaceuticals

aquavitpharma.com

Avior Bio logo

Avior Bio

Gerostate Alpha logo

Gerostate Alpha

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Aquinnah Pharmaceuticals logo

Aquinnah Pharmaceuticals

aquinnahpharma.com

Navitor Pharmaceuticals logo

Navitor Pharmaceuticals

Alzheon logo

Alzheon

alzheon.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Aristea Therapeutics logo

Aristea Therapeutics

Aeovian Pharmaceuticals - Quick Facts

Who are Aeovian Pharmaceuticals' competitors?

Companies similar to Aeovian Pharmaceuticals include Azevan Pharmaceuticals, Avalyn Pharma, Aria Pharmaceuticals and Abvc Biopharma.

When was Aeovian Pharmaceuticals founded?

Aeovian Pharmaceuticals was founded in 2012.

Where is Aeovian Pharmaceuticals' headquarters located?

Aeovian Pharmaceuticals' headquarters is located in San Francisco, CA, US.

When was Aeovian Pharmaceuticals' last funding round?

Aeovian Pharmaceuticals' most recent funding round was for $37M (USD) in October 2019.

How much has Aeovian Pharmaceuticals raised to-date?

As of Oct 3, 2019, Aeovian Pharmaceuticals has raised a total of $37.8M (USD).

How many employees does Aeovian Pharmaceuticals have?

Aeovian Pharmaceuticals has 13 employees as of Feb 5, 2024.

Aeovian Pharmaceuticals - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified